Literature DB >> 6292476

Hybrid selection of small RNAs by using simian virus 40 DNA: evidence that the simian virus 40-associated small RNA is synthesized by specific cleavage from large viral transcripts.

J C Alwine.   

Abstract

The simian virus 40 (SV40)-associated small RNA (SAS-RNA), approximately 64 nucleotides, is virally encoded within a region of the viral late (+) DNA strand which encodes no known protein. The SAS-RNA arises in abundance late in SV40 lytic infection. Previous data indicate that the synthesis of the SAS-RNA may be under the control of the normal late viral promoter; i.e., inhibition of transcription from the late promoter results in cessation of SAS-RNA synthesis. The synthesis of SAS-RNA was examined to determine whether the SAS-RNA is the product of cleavage from noncoding regions of nuclear late transcripts or an independent transcription product like 5S RNA, or the adenovirus VA-RNAs. The data described below suggest that SAS-RNA is cleaved from large late transcripts. In vitro transcription of DNA fragments containing the SAS-RNA coding region yielded no SAS-RNA synthesis; this result was supported by DNA sequence analysis, which indicated no promoter-like regions either within or flanking the SAS-RNA coding region. In support of a cleavage mechanism, the SAS-RNA has a 3'-phosphate end, an occurrence which is indicative of nuclease cleavage. In addition, 5'-end labeling of the SAS-RNA was possible only after calf alkaline phosphatase treatment; this indicates that the SAS-RNA is not capped. Hybrid selection analysis was used to demonstrate that separation of the SAS-RNA coding region from the normal late promoter resulted in elimination of SAS-RNA synthesis. This was demonstrated in SV40-transformed cells in which integration of a single copy of SV40 breaks the continuity of the late coding region, so that the SAS-RNA coding region is physically separated from the normal late promoter. The lack of SAS-RNA synthesis indicates that the SAS-RNA coding region cannot function as a primary transcription unit. The same result and conclusion were obtained by using a permissive cell line transformed by SV40 (COS-1 cells); here it was found that the integrated SAS-RNA coding region was not expressed even during a viable lytic infection in which the SAS-RNA could be expressed from the infecting viral genomes. The simplest conclusion drawn from the data is that the SAS-RNA is cleaved from larger late transcripts which initiate at the normal late promoter. This conclusion suggests that many of the small RNAs found in normal eucaryotic cells may be synthesized by specific cleavage rather than by primary transcription. In the course of these studies several small cellular RNAs were detected, due to their specific hybrid selection, by using SV40 DNA. Primary mapping and characterization data of these RNAs are also presented.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292476      PMCID: PMC256209     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Location of sequences on the adenovirus genome coding for the 5.5S RNA.

Authors:  U Pettersson; L Philipson
Journal:  Cell       Date:  1975-09       Impact factor: 41.582

2.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

3.  Small RNA species of the HeLa cell: metabolism and subcellular localization.

Authors:  G Zieve; S Penman
Journal:  Cell       Date:  1976-05       Impact factor: 41.582

4.  A novel RNA affecting embryonic gene functions in early chick glastoderm.

Authors:  A K Deshpande; S B Jakowlew; H H Arnold; P A Crawford; M A Siddiqui
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Studies on the origin of a low molecular weight ribonucleic acid from human cells infected with adenoviruses.

Authors:  K Ohe; S M Weissman; N R Cooke
Journal:  J Biol Chem       Date:  1969-10-10       Impact factor: 5.157

7.  Small molecular weight monodisperse nuclear RNA.

Authors:  R A Weinberg; S Penman
Journal:  J Mol Biol       Date:  1968-12       Impact factor: 5.469

8.  Low molecular weight viral RNAs transcribed by RNA polymerase III during adenovirus 2 infection.

Authors:  R Weinmann; T G Brendler; H J Raskas; R G Roeder
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

9.  Role of DNA-dependent RNA polymerase 3 in the transcription of the tRNA and 5S RNA genes.

Authors:  R Weinmann; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei.

Authors:  N Dwyer; G Blobel
Journal:  J Cell Biol       Date:  1976-09       Impact factor: 10.539

View more
  5 in total

1.  Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins.

Authors:  J C Alwine
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

2.  Efficient and accurate in vitro processing of simian virus 40-associated small RNA.

Authors:  N Hay; O Amster-Choder; Y Aloni
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Sequences on the 3' side of hexanucleotide AAUAAA affect efficiency of cleavage at the polyadenylation site.

Authors:  M Sadofsky; J C Alwine
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

Review 4.  Polyomavirus miRNAs: the beginning.

Authors:  Michael J Imperiale
Journal:  Curr Opin Virol       Date:  2014-04-17       Impact factor: 7.090

5.  Attenuation of late simian virus 40 mRNA synthesis is enhanced by the agnoprotein and is temporally regulated in isolated nuclear systems.

Authors:  N Hay; Y Aloni
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.